Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy

Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy

Abstract Objectives Adult-onset Still’s disease (AOSD) phenotype appears to be dichotomized in systemic or chronic articular forms. As biologicals and particularly interleukin (IL)-1 and IL-6 blockers play a more and more prominent role in the treatment, their place requires clarification. This stud...

Full description

Bibliographic Details
Main Authors: François Vercruysse, Thomas Barnetche, Estibaliz Lazaro, Emilie Shipley, François Lifermann, Alexandre Balageas, Xavier Delbrel, Bruno Fautrel, Christophe Richez, Thierry Schaeverbeke, Marie-Elise Truchetet
Format: Article
Language:English
Published: BMC 2019-02-01
Series:Arthritis Research & Therapy
Subjects:
Adult-onset Still’s disease
Tocilizumab
Anakinra
Treatment strategy
Biologics
Online Access:http://link.springer.com/article/10.1186/s13075-019-1838-6

Similar Items

Similar Items